{"id":226271,"date":"2023-07-24T11:22:59","date_gmt":"2023-07-24T10:22:59","guid":{"rendered":"https:\/\/clarivate.com\/?p=226271"},"modified":"2026-03-20T13:37:12","modified_gmt":"2026-03-20T13:37:12","slug":"pharmas-and-medtechs-flex-brand-protection-among-top-100-new-brands-for-2023","status":"publish","type":"post","link":"https:\/\/clarivate.com\/intellectual-property\/blog\/pharmas-and-medtechs-flex-brand-protection-among-top-100-new-brands-for-2023\/","title":{"rendered":"Pharmas and medtechs flex brand protection among Top 100 New Brands for 2023"},"content":{"rendered":"<p>Biopharma and medtech brands made up a dozen of the Clarivate Top 100 New Brands for 2023, as the life science industries continued to show a muscular approach to protecting their intellectual property.<\/p>\n<p>The \u00a0findings put the life science industries on favorable terms with consumer-facing giants like Apple (which counted five brands among the top 100), Huawei (5) and Hugo Boss (4) \u2013 all the more remarkable as pharma and medtech brands are generally not sold direct-to-consumer.<\/p>\n<p><a href=\"http:\/\/clarivate.com\/intellectual-property\/wp-content\/uploads\/sites\/5\/2023\/07\/graphics-for-top-100-lsh-blog-e1690205470417.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-226272 size-full\" src=\"http:\/\/clarivate.com\/intellectual-property\/wp-content\/uploads\/sites\/5\/2023\/07\/graphics-for-top-100-lsh-blog-e1690205470417.jpg\" alt=\"\" width=\"1121\" height=\"611\" srcset=\"https:\/\/clarivate.com\/intellectual-property\/wp-content\/uploads\/sites\/5\/2023\/07\/graphics-for-top-100-lsh-blog-e1690205470417.jpg 1121w, https:\/\/clarivate.com\/intellectual-property\/wp-content\/uploads\/sites\/5\/2023\/07\/graphics-for-top-100-lsh-blog-e1690205470417-300x164.jpg 300w, https:\/\/clarivate.com\/intellectual-property\/wp-content\/uploads\/sites\/5\/2023\/07\/graphics-for-top-100-lsh-blog-e1690205470417-1024x558.jpg 1024w, https:\/\/clarivate.com\/intellectual-property\/wp-content\/uploads\/sites\/5\/2023\/07\/graphics-for-top-100-lsh-blog-e1690205470417-768x419.jpg 768w, https:\/\/clarivate.com\/intellectual-property\/wp-content\/uploads\/sites\/5\/2023\/07\/graphics-for-top-100-lsh-blog-e1690205470417-73x40.jpg 73w\" sizes=\"auto, (max-width: 1121px) 100vw, 1121px\" \/><\/a><\/p>\n<p><small>Source: Clarivate Trademark Strength Index and CompuMark data covering 145 million individual trademark records<\/small><\/p>\n<p>Notable of this year\u2019s list:<\/p>\n<ul>\n<li>BioNTech appears twice, first for the German biotech\u2019s corporate brand, which achieved global household name status as a result of its revolutionary mRNA COVID-19 vaccine, and again for its BioNTainer mRNA production platform. BioNTainer features modular production units, GMP-compliant setup and personnel training, with each unit designed to function as a regional node in a global manufacturing network for rapid response to infectious disease outbreaks.<\/li>\n<li>Incyte also notches two mentions, first for the U.S.-based company\u2019s topical JAK inhibitor for nonsegmental vitiligo and atopic dermatitis in patients ages 12 and up, OPZELURA\u2122, and again for QPARIK\u00ae, a registration covering prospective treatments for oncological, autoimmune, hematological and treatment graft versus host disorders.<\/li>\n<li>Medtech is holding its own here, with multiple trademarks including Zimmer Biomet\u2019s dental and spine business spinoff ZimVie and bioMerieux\u2019s stackable benchtop automated immunoassay solution VIDAS\u00ae KUBE\u2122.<\/li>\n<li>Across all sectors, the advent of AI was one of this year\u2019s notable trends, and the inclusion of Bayer\u2019s Cal.AI (Calantic\u2122) radiology solutions suite reflects this.<\/li>\n<li>In geographic terms, this year\u2019s life science brands leaned toward Europe, with Germany and Switzerland accounting for six, and France and the U.K. one apiece. U.S.-based companies accounted for three brands and South Korea one. Beyond the life sciences, this year\u2019s report featured a very strong showing from companies based in Mainland China, accounting for 27 brands.<\/li>\n<\/ul>\n<p>To identify the Top 100 New Brands for 2023, analysts used Clarivate global trademark data covering 145 million individual trademark records to analyze applications filed worldwide between 2021 and 2022 with a verbal element. Brands were scored based on market footprint and geographic\/economic coverage for each.<\/p>\n<p>Read the full report <a href=\"https:\/\/clarivate.com\/lp\/top-100-new-brands-2023\">here<\/a>, and to learn more about Clarivate brand IP intelligence and trademark analytics solutions, please <a href=\"https:\/\/clarivate.com\/contact-top-100-new-brands\/\">contact us here<\/a>. Learn more about the broader Clarivate connected data and solutions offerings for the life sciences <a href=\"https:\/\/clarivate.com\/industries\/life-sciences-and-healthcare\/\">here<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Biopharma and medtech brands made up a dozen of the Clarivate Top 100 New Brands for 2023, as the life science industries continued to show a muscular approach to protecting&#8230;<\/p>\n","protected":false},"author":45,"featured_media":265671,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[42,2142,706],"tags":[1181,40,1163,872,1271,1267],"class_list":["post-226271","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-patents","category-brand-ip","category-trademarks","tag-corporate","tag-ip-intelligence","tag-ip-lifecycle-management","tag-ip-services","tag-pharma","tag-research-commercialization","clarivate-industry-life-sciences-and-healthcare"],"acf":[],"lang":"en","translations":{"en":226271},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"pll_sync_post":[],"_links":{"self":[{"href":"https:\/\/clarivate.com\/intellectual-property\/wp-json\/wp\/v2\/posts\/226271","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/intellectual-property\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/clarivate.com\/intellectual-property\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/clarivate.com\/intellectual-property\/wp-json\/wp\/v2\/users\/45"}],"replies":[{"embeddable":true,"href":"https:\/\/clarivate.com\/intellectual-property\/wp-json\/wp\/v2\/comments?post=226271"}],"version-history":[{"count":2,"href":"https:\/\/clarivate.com\/intellectual-property\/wp-json\/wp\/v2\/posts\/226271\/revisions"}],"predecessor-version":[{"id":287353,"href":"https:\/\/clarivate.com\/intellectual-property\/wp-json\/wp\/v2\/posts\/226271\/revisions\/287353"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/clarivate.com\/intellectual-property\/wp-json\/wp\/v2\/media\/265671"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/intellectual-property\/wp-json\/wp\/v2\/media?parent=226271"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/clarivate.com\/intellectual-property\/wp-json\/wp\/v2\/categories?post=226271"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clarivate.com\/intellectual-property\/wp-json\/wp\/v2\/tags?post=226271"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}